Search
Plus Therapeutics Inc
PSTVAdd to Watchlist
3.870USD
0.0000.00%
Close 07-31 16:00（ET）
24.21MMarket Cap
LossP/E TTM
PSTV Financials
See Plus Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
24.21M
Dividend TTM
0.00
P/E TTM
-1.12
EPS TTM
-3.46
Revenue
5.21M
Net Profit
-12.98M
ROE
-522.50%
ROA
-74.63%
Plus Therapeutics Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
-26.13/-0.88
Revenue / Forecast
1.03M/974.00K
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
Revenue
By Business
Period:
No Data
By Region
Period:No Data
FAQs
What is the total revenue of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its total revenue reached 5.21M, with a year-on-year change of 5.82M.
What are the current assets of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its current assets were 15.17M, with a year-on-year change of 188.46.
What are the total assets of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its total assets of Plus Therapeutics Inc were 16.32M, with a year-on-year change of 146.12.
What are the total liabilities of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its total liabilities of Plus Therapeutics Inc were 12.33M, with a year-on-year change of -20.88.
What is the total equity of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its total equity of Plus Therapeutics Inc was 4.00M, with a year-on-year change of 144.65.
What is the net operating income of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its net operating income of Plus Therapeutics Inc was -15.30M, with a year-on-year change of -4.10.
What is the net investment of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its net investment of Plus Therapeutics Inc was -854.00K, with a year-on-year change of 79.23.
What is the net financing of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its net financing of Plus Therapeutics Inc was 30.31M, with a year-on-year change of 389.91.
What is the Earnings Per Share (EPS) of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -7.19, with a year-on-year change of 85.28.
What is the net income of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its net income was -22.39M, with a year-on-year change of -72.49.
What is the net margin of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its net profit margin was -429.43, with a year-on-year change of -92.71.
What is the debt-to-asset ratio of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 4.59, with a year-on-year change of -90.74.
What is the Return on Assets (ROA) of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -195.02, with a year-on-year change of -35.40.
What is the operating profit of Plus Therapeutics Inc?
According to Plus Therapeutics Inc's FY2025 earnings report, its operating profit was -15.30M, with a year-on-year change of -4.10.